Business Context and Reporting Period
Company: Neuralstem, Inc. (Note: Metadata referenced "Palisade Bio, Inc." but the filing text identifies the registrant as Neuralstem, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: August 15, 2018
Reporting Period: Three and six months ended June 30, 2018
Context: The filing reports financial results and provides updates on clinical programs and business highlights via an attached press release (Exhibit 99.01).
Key Financial Metrics
The provided text serves as a cover sheet for the Form 8-K and does not contain specific numerical data. The filing states that financial results for the three and six months ended June 30, 2018, are reported in the attached press release (Exhibit 99.01). Consequently, the following metrics are not available in the source text:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus prior periods. It only indicates that an update on clinical programs and business highlights was provided in the referenced press release.
Guidance, Outlook, and Risks
Outlook and Commentary: Management provided an update on clinical programs and business highlights, though specific details are contained in the attached Exhibit 99.01 and not in the main filing text.
Risks and Contingencies: The filing includes a standard disclaimer stating that information furnished under Item 2.02 and Exhibit 99.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liability of such section. It also notes that this information is not incorporated by reference into subsequent filings unless specifically stated.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) in the attached Press Release (Exhibit 99.01) as they are not listed in the 8-K cover text.
- Review the clinical program updates and business highlights detailed in the press release to assess operational progress.
- Confirm the company name discrepancy between the request metadata ("Palisade Bio, Inc.") and the filing registrant ("Neuralstem, Inc.").
- Note that the financial data in the press release is not legally "filed" under Section 18 of the Exchange Act per the disclaimer in this report.